nifedipine has been researched along with Cherry Red Spot Myoclonus Syndrome in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimura, F | 1 |
| Naruishi, H | 1 |
| Naruishi, K | 1 |
| Yamada, T | 1 |
| Sasaki, J | 1 |
| Peters, C | 1 |
| Uchiyama, Y | 1 |
| Murayama, Y | 1 |
1 other study available for nifedipine and Cherry Red Spot Myoclonus Syndrome
| Article | Year |
|---|---|
Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice.
Topics: Animals; Calcium; Calcium Channel Blockers; Cathepsin B; Cathepsin L; Cathepsins; Cells, Cultured; C | 2002 |